Edition:
United Kingdom

Vital Therapies Inc (VTL.OQ)

VTL.OQ on NASDAQ Stock Exchange Global Select Market

9.00USD
17 Aug 2018
Change (% chg)

$-0.10 (-1.10%)
Prev Close
$9.10
Open
$9.05
Day's High
$9.15
Day's Low
$8.80
Volume
56,135
Avg. Vol
66,899
52-wk High
$9.70
52-wk Low
$2.70

Chart for

About

Vital Therapies, Inc. is a biotherapeutic company. The Company is focused on developing a human hepatic cell-based treatment targeting acute forms of liver failure. Its product candidate, the ELAD System, is an extracorporeal human allogeneic cellular liver therapy designed to allow the patient's liver to regenerate to a healthy... (more)

Overall

Beta: 5.35
Market Cap(Mil.): $249.02
Shares Outstanding(Mil.): 42.21
Dividend: --
Yield (%): --

Financials

  VTL.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.37 -- --
ROI: -63.60 1.78 14.61
ROE: -63.63 3.28 16.33

BRIEF-Vital Therapies Q1 Loss Per Share $0.34

* VITAL THERAPIES ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

08 May 2018

BRIEF-Vital Therapies Announces VTL-308 Reaches Enrollment Target Of 150 Subjects

* VITAL THERAPIES ANNOUNCES VTL-308 REACHES ENROLLMENT TARGET OF 150 SUBJECTS

22 Mar 2018

BRIEF-Vital Therapies Announces Q4 Loss Per Share $0.35

* VITAL THERAPIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

13 Mar 2018

Earnings vs. Estimates